These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 11735616

  • 1. Frovatriptan.
    Easthope SE, Goa KL.
    CNS Drugs; 2001; 15(12):969-76; discussion 977-8. PubMed ID: 11735616
    [Abstract] [Full Text] [Related]

  • 2. Frovatriptan: a review of its use in the acute treatment of migraine.
    Sanford M.
    CNS Drugs; 2012 Sep 01; 26(9):791-811. PubMed ID: 22900951
    [Abstract] [Full Text] [Related]

  • 3. Frovatriptan review.
    Markus F, Mikko K.
    Expert Opin Pharmacother; 2007 Dec 01; 8(17):3029-33. PubMed ID: 18001261
    [Abstract] [Full Text] [Related]

  • 4. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan.
    Géraud G, Spierings EL, Keywood C.
    Headache; 2002 Apr 01; 42 Suppl 2():S93-9. PubMed ID: 12028325
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic evaluation of frovatriptan.
    Negro A, Lionetto L, Casolla B, Lala N, Simmaco M, Martelletti P.
    Expert Opin Drug Metab Toxicol; 2011 Nov 01; 7(11):1449-58. PubMed ID: 21929465
    [Abstract] [Full Text] [Related]

  • 6. Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine.
    Balbisi EA.
    Int J Clin Pract; 2004 Jul 01; 58(7):695-705. PubMed ID: 15311727
    [Abstract] [Full Text] [Related]

  • 7. Frovatriptan: pharmacological differences and clinical results.
    Rapoport AM.
    Curr Med Res Opin; 2001 Jul 01; 17 Suppl 1():s68-70. PubMed ID: 12463282
    [Abstract] [Full Text] [Related]

  • 8. Dose range-finding studies with frovatriptan in the acute treatment of migraine.
    Rapoport A, Ryan R, Goldstein J, Keywood C.
    Headache; 2002 Apr 01; 42 Suppl 2():S74-83. PubMed ID: 12028323
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.
    Savi L, Mogavero S, Egan CG.
    Drug Des Devel Ther; 2014 Apr 01; 8():983-92. PubMed ID: 25092964
    [Abstract] [Full Text] [Related]

  • 10. Frovatriptan for the acute treatment of migraine: a dose-finding study.
    Goldstein J, Keywood C, 251/96/14 Study Group.
    Headache; 2002 Jan 01; 42(1):41-8. PubMed ID: 12005274
    [Abstract] [Full Text] [Related]

  • 11. Frovatriptan: a selective type 1B/1D serotonin receptor agonist for the treatment of migraine headache.
    Cole P, Rabasseda X.
    Drugs Today (Barc); 2002 Sep 01; 38(9):615-29. PubMed ID: 12582449
    [Abstract] [Full Text] [Related]

  • 12. Almotriptan: a review of its use in migraine.
    Keam SJ, Goa KL, Figgitt DP.
    Drugs; 2002 Sep 01; 62(2):387-414. PubMed ID: 11817980
    [Abstract] [Full Text] [Related]

  • 13. Clinical efficacy of frovatriptan: placebo-controlled studies.
    Ryan R, Géraud G, Goldstein J, Cady R, Keywood C.
    Headache; 2002 Apr 01; 42 Suppl 2():S84-92. PubMed ID: 12028324
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of two 6-day frovatriptan dosing regimens used for the short-term prevention of menstrual migraine: A phase I, randomized, double-blind, placebo-controlled, two-period crossover, single-centre study in healthy female volunteers.
    Wade A, Pawsey S, Whale H, Boyce M, Warrington S.
    Clin Drug Investig; 2009 Apr 01; 29(5):325-37. PubMed ID: 19366274
    [Abstract] [Full Text] [Related]

  • 15. Rizatriptan: an update of its use in the management of migraine.
    Wellington K, Plosker GL.
    Drugs; 2002 Apr 01; 62(10):1539-74. PubMed ID: 12093318
    [Abstract] [Full Text] [Related]

  • 16. Spotlight on almotriptan in migraine.
    Keam SJ, Goa KL, Figgitt DP.
    CNS Drugs; 2002 Apr 01; 16(7):501-7. PubMed ID: 12056924
    [Abstract] [Full Text] [Related]

  • 17. Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies.
    MacGregor EA, Pawsey SP, Campbell JC, Hu X.
    Gend Med; 2010 Apr 01; 7(2):88-108. PubMed ID: 20435272
    [Abstract] [Full Text] [Related]

  • 18. Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting.
    Guidotti M, Ravasio R.
    Clin Drug Investig; 2009 Apr 01; 29(11):693-702. PubMed ID: 19813772
    [Abstract] [Full Text] [Related]

  • 19. Clinical pharmacokinetics of frovatriptan.
    Buchan P, Keywood C, Wade A, Ward C.
    Headache; 2002 Apr 01; 42 Suppl 2():S54-62. PubMed ID: 12028321
    [Abstract] [Full Text] [Related]

  • 20. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
    Silberstein SD, Elkind AH, Schreiber C, Keywood C.
    Neurology; 2004 Jul 27; 63(2):261-9. PubMed ID: 15277618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.